InvestorsHub Logo
Followers 1
Posts 127
Boards Moderated 0
Alias Born 02/15/2018

Re: None

Sunday, 07/08/2018 10:38:53 AM

Sunday, July 08, 2018 10:38:53 AM

Post# of 3329
psea 9 hours ago
@Chris it's already been forwarded to an attorney. Just amazes me investors don't see how small of a pie we get w/ Vifor and Otsuka taking their parts.

Shameful mgmt only pitched the upside....in 5 yrs...possibly.
___________________________

@psea ALL following as per my hypothetical analysis and IMO.

The KERX/AKBA “merger”
swindle should have NEVER been proposed — they screwed-up BIGTIME. The correlation between the 2 companies is TOTALLY out-of-whack. KERX with twice FDA approved and EU approved blockbuster potential Auryxia well into commercialization and ALL structure in place — while AKBA with Vadadustat still in late-stage clinicals YEARS away from commercialization., IF APPROVED. What is happening is that they are trying to shove/cram this “merger” swindle to fit their schedule and timing for execution of end game at year-end 2018. They are trying to shove/cram “merger” swindle down everybodies throat employing AKBA’s $400+ million cash in balance sheet as “bait” to camouflage the fact that the “merger” swindle is TOTALLY out-of-whack.

Let me explain as follows, again, as per my hypothetical analysis and IMO.

The original plan for merging KERX mid-year 2018 was never AKBA, it was RMTI as had been posting since months ago. You see, the correlation between KERX and RMTI is NOT out-of-whack, it’s much more sellable in terms of employing a “merger” swindle. RMTI has 2 FDA approved drugs (Triferic the important one, Calcitriol the other) and 52 million O/S. A KERX/RMTI “merger” swindle with similar if not same criminal conversion ration of .3743 (again, RMTI at 52 million O/S) was originally planned and would have been sold as RMTI having 2 FDA approved drugs versus KERX’s one with Triferic also having blockbuster potential.

But the crooks ran into a quagmire when they ousted RMTI’s CEO Chioini and CFO Klema via RMTI’s BOD with has recently designated new Directors (you need to have knowledge of RMTI’s story is to fully understand) — the quagmire is that Chioini and Klema were/are fighting back in Court of Law and a BIG legal mess prevails at RMTI which will potentially take MONTHS to resolve absent an agreement between 2 parties in legal battle.

Sooo, the KERX/RMTI merger became NOT DOABLE as planned and, again, they’re running on a schedule — so the shoved, crammed, TOTALLY out-of-whack KERX/AKBA “merger”
swindle was born.

The sheet runs DEEP, they screwed-up BIGTIME, and the KERX/AKBA “merger” is the swindle of all swindles, Your write-up is excellent, on point, but understand, the sheet runs DEEP and it will hit the fan if they don’t take a step back.

Let the thumbs-down commence.

ALL above, in my opinion, as always — hypothetical analysis


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.